Receive assistance to promote humane drug policy
Eurasian Harm Reduction Association (EHRA) would like to inform you about the possibility of obtaining resource assistance/funding for initiative groups Read more.
Thinking outside the box: overcoming challenges in community advocacy for sustainable and high-quality HIV services
Three Eurasian networks – EHRA, ECOM and EWNA united by the Eurasian Regional Consortium, met in Vilnius to discuss innovative Read more.
ENPUD Speech during the CND2019
15 March, 2019, Vienna, CND. Eurasian Network of People Who Use Drugs (ENPUD) direct speech at the Interactive roundtable: “Safeguarding Read more.
Statement from the Eurasian Harm Reduction Association on Ministerial Declaration Read more.
Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to HIV and harm reduction services
New report by UNAIDS highlights the urgent need to implement a human rights and evidence- informed approach to reach people Read more.
People who use drugs vs Governments of Estonia and Kazakhstan at the 65 session of the CESCR
Geneva, 65 session of the UN Committee on Economic, Social and Cultural Rights February 18 – March 8, 2019 In Read more.
ToR for consultant to develop the Framework, Methodology and Instrument(s)
EHRA is looking for the consultant to develop the Framework, Methodology and Instrument(s) to assess the impact of the transition from Read more.
Developing the capacity of CCM members representing civil society in Central Asia: a two-day workshop took place in Almaty, Kazakstan
On February 13-14, 2019 in Almaty, Kazakhstan, the Eurasian Harm Reduction Association (EHRA), within the framework of the Regional Communication Read more.
EHRA and the Alliance for Public Health call to join the Valentine’s Day Global Action in support of the Global Fund’s efforts to ensure the necessary level of investment within
On the 11th January 2019, the Global Fund announced its fundraising target for the next three-year cycle for 2020 – Read more.